RAPT Therapeutics Inc
RAPT
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
RAPT Therapeutics is a clinical-stage biopharmaceutical company engaged in the research and development of human therapeutic products. As part of its preclinical drug development pipeline, the company conducts or contracts for animal testing to assess the safety and efficacy of its investigational candidates. This reliance on animal models is a standard, yet exclusionary, practice in the biopharmaceutical industry for companies without approved products on the market.
A specific incident highlighting the risks of this activity involves a former Tufts School of Medicine researcher, suspended from animal work in 2023 following repeated animal welfare violations, who was previously a scientific founder and consultant for RAPT. This connection underscores the systemic animal welfare concerns inherent in the preclinical research ecosystem upon which the company depends. The available evidence does not specify the scale or nature of RAPT's direct animal testing operations.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.